- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03279510
Hearing Aids and the Brain
March 23, 2023 updated by: VA Office of Research and Development
Hearing aids are being fit on inexperienced hearing aid users and the short-term and long-term effects are measured.
This research aims to improve understanding of the individual factors that contribute to receiving benefit from hearing aids and lead to more individualized treatment of hearing loss.
Study Overview
Detailed Description
Hearing aids are used to improve audibility for patients with hearing loss and improve speech perception.
In addition to these immediate benefits, amplification has the potential to have long-term effects on higher level auditory processing abilities, such as cognition or other abilities required for complex listening tasks.
These long-term acclimatization effects are not well understood and merit further behavioral and physiological examination.
Hearing aids will be fit on inexperienced hearing aid users and outcome measures will be used to determine immediate and long-term effects of hearing aids.
This research may provide a more detailed view of individual differences that contribute to receiving benefit from a hearing aid and may lead to more individualized treatment of hearing loss.
Study Type
Interventional
Enrollment (Actual)
20
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Oregon
-
Portland, Oregon, United States, 97239
- VA Portland Health Care System, Portland, OR
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
50 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- 50 years of age or older
- Bilateral, mild to moderately severe hearing loss
- Inexperienced hearing aid users
Exclusion Criteria:
- Subject deciding that they do not wish to wear hearing aids as necessitated per study protocol
- Audiometric thresholds that suggest research stimuli would not be audible
- Conductive hearing loss and/or other significant ear or hearing problems
- Non-native English speakers
- Conditions or circumstances that would preclude a participant from wearing hearing aids consistently or finishing the study
- An inability to perform or complete the experimental tasks
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Hearing aids
All study participants will be fit with hearing aids.
|
Subjects are fit with hearing aids.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Evoked potential latency
Time Frame: Approximately 1 year
|
Latency will be measured in milliseconds
|
Approximately 1 year
|
Evoked potential amplitude
Time Frame: Approximately 1 year
|
Amplitude will be measured in microvolts
|
Approximately 1 year
|
Frequency following response magnitude
Time Frame: Approximately 1 year
|
Magnitude of response measured in nanovolts
|
Approximately 1 year
|
Frequency following response timing
Time Frame: Approximately 1 year
|
Timing measured by cross-correlation between stimulus and response
|
Approximately 1 year
|
Ongoing electroencephalography power
Time Frame: Approximately 1 year
|
EEG power as a function of frequency recorded during words-in-noise measure
|
Approximately 1 year
|
Montreal Cognitive Assessment score
Time Frame: Approximately 1 year
|
Assessment score from 1 to 30
|
Approximately 1 year
|
Reading Span
Time Frame: Approximately 1 year
|
Percent correct recall on working memory task
|
Approximately 1 year
|
Hearing aid usage
Time Frame: Approximately 1 year
|
Data logging from the hearing aid will provide usage in hours per day
|
Approximately 1 year
|
Word-in-noise perception testing
Time Frame: Approximately 1 year
|
Signal-to-noise ratio at which participant correctly understands 50% of speech in noise using WIN test
|
Approximately 1 year
|
Listening invested/required effort
Time Frame: Approximately 1 year
|
Participants' rating of the effort required (0-9) and invested (0-9) for listening task
|
Approximately 1 year
|
Working memory testing
Time Frame: Approximately 1 year
|
Performance on auditory working memory task
|
Approximately 1 year
|
Glasgow Hearing Aid Benefit Profile (GHABP)
Time Frame: Approximately 1 year
|
Participants rating on five-point scale their perceived initial (i.e., unaided) hearing disability, initial handicap, aided benefit, aided handicap, HA use and HA satisfaction in four listening situations
|
Approximately 1 year
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
March 22, 2018
Primary Completion (Actual)
January 31, 2021
Study Completion (Actual)
January 31, 2021
Study Registration Dates
First Submitted
August 23, 2017
First Submitted That Met QC Criteria
September 8, 2017
First Posted (Actual)
September 12, 2017
Study Record Updates
Last Update Posted (Actual)
March 24, 2023
Last Update Submitted That Met QC Criteria
March 23, 2023
Last Verified
March 1, 2023
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- C2396-P
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
Yes
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Hearing Loss
-
MED-EL Elektromedizinische Geräte GesmbHCompletedHearing Loss | Hearing Loss, Sensorineural | Hearing Loss, Bilateral | Hearing Loss, Conductive | Hearing Loss, Unilateral | Hearing Loss, MixedAustria, Germany, United Kingdom
-
University of California, San FranciscoPatient-Centered Outcomes Research InstituteRecruitingHearing Loss | Hearing Loss, Sensorineural | Hearing Loss, Bilateral | Hearing Loss, Conductive | Hearing Loss, Noise-Induced | Hearing Loss, Unilateral | Hearing Loss, Mixed | Hearing Disorders in ChildrenUnited States
-
Oticon MedicalRecruitingEar Diseases | Hearing Loss, Conductive | Hearing Loss Mixed | Hearing Disability | Conductive Hearing Loss | Conductive Hearing Loss, Bilateral | Conductive Hearing Loss, UnilateralUnited Kingdom
-
Oticon MedicalNot yet recruitingSensorineural Hearing Loss, Bilateral | Sensorineural Hearing Loss, Severe | Sensorineural Hearing Loss, Profound
-
Manchester University NHS Foundation TrustUniversity of ManchesterCompletedCochlear Hearing Loss | Sensorineural Hearing Loss, BilateralUnited Kingdom
-
Oticon MedicalCompletedConductive Hearing Loss | Conductive and Sensori-neural Hearing Loss in the Same Ear | Unilateral, Profound Sensori-neural Hearing LossUnited States
-
Frequency TherapeuticsCompletedHearing Loss, Sensorineural | Presbycusis | Noise Induced Hearing Loss | Sudden Hearing LossUnited States
-
Frequency TherapeuticsCompletedHearing Loss, Sensorineural | Noise Induced Hearing Loss | Sudden Hearing LossUnited States
-
Otologic Pharmaceutics, Inc.CompletedHearing Loss | Sensorineural Hearing Loss | Noise-Induced Hearing LossUnited States
-
Otologics LLCUnknownMixed Conductive and Sensorineural Hearing Loss, Bilateral
Clinical Trials on hearing aids
-
Sonova AGToronto Metropolitan UniversityNot yet recruiting
-
University Hospital, ToursCompletedHearing Loss | Alzheimer's DiseaseFrance
-
Jong Woo ChungCompletedAuditory Processing Disorder, CentralKorea, Republic of
-
Sonova AGCompletedSensorineural Hearing LossSwitzerland
-
Northwestern UniversityUniversity of Colorado, BoulderEnrolling by invitation
-
Sonova AGWestern University, Canada; Sonova Canada Inc.Recruiting
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityRecruitingHearing Loss, Sensorineural | Cognitive Function Abnormal | Age-related Hearing Loss | Hearing AidChina
-
Manchester University NHS Foundation TrustUniversity of ManchesterCompletedCochlear Hearing Loss | Sensorineural Hearing Loss, BilateralUnited Kingdom
-
Technical University of DenmarkCompleted
-
Northwestern UniversityActive, not recruitingHearing Loss | Hearing Loss, Sensorineural | Hearing Loss, BilateralUnited States